Clinical
Trials
Clinical trials study potential new treatments that may slow PSC disease progression, manage symptoms, or otherwise improve PSC care. Your participation in clinical trials can help bring us closer to a cure for PSC.
It is always your choice to participate in a study, and you can withdraw at any time. Every study listed below is completely confidential and will not reveal identifying patient information to others.
Types of Clinical Studies
Interventional Trials
Participants receive specific interventions, such as drugs or devices, to evaluate their safety and effectiveness in treating PSC.
Observational Studies
Researchers collect real-world data from participants in their current life. No intervention (change) is made in participant medications or care. These studies may collect previous health history or prospectively enroll patients to follow them over time
Registry-Based Studies
In addition to the PSC Partners Patient Registry, other registries are open to people living with PSC. You can join multiple registries if you match the requirements for each registry.
Ongoing Trials & Studies
The Four Phases of Clinical Trials
1
Safety
Confirming a treatment is safe in humans; Typically 20-100 healthy individuals; Several months
2
Early effectiveness & dosing
Preliminary proof of effectiveness and safety data; Typically 100-300 patients with PSC; Several months to 2 years
3
Confirming effectiveness
The key study to confirm effectiveness and safety before approval; Typically hundreds of patients with PSC; 1 to 5 years
4
Post-approval monitoring
Long term observation; Thousands of people receiving the treatment; Several years
Partner Clinical Trial Resources
We collaborate with trusted organizations to bring you the most comprehensive research opportunities.
Cholangiocarcinoma Foundation
A non-profit dedicated to curing cholangiocarcinoma
PSC Support (UK)
The only UK charity dedicated to improving the lives of people affected by PSC
